Impact of gp120 on Dendritic Cell-Derived Chemokines: Relevance for the Efficacy of gp120-Based Vaccines for HIV-1 - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Clinical and Vaccine Immunology Year : 2012

Impact of gp120 on Dendritic Cell-Derived Chemokines: Relevance for the Efficacy of gp120-Based Vaccines for HIV-1

Domains

Innate immunity Allergology

Jagadeesh Bayry  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-02455549

Submitted on : Sunday, January 26, 2020-11:43:35 AM

Last modification on : Friday, May 26, 2023-11:18:09 AM

Consult the full text

Dates and versions

inserm-02455549 , version 1 (26-01-2020)

Identifiers

Cite

Janakiraman Vani, Meenu Sharma, Melkote Shaila, Srini V. Kaveri, Jagadeesh Bayry. Impact of gp120 on Dendritic Cell-Derived Chemokines: Relevance for the Efficacy of gp120-Based Vaccines for HIV-1. Clinical and Vaccine Immunology, 2012, 19 (8), pp.1335-1336. ⟨10.1128/CVI.00244-12⟩. ⟨inserm-02455549⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UNIV-PARIS7 UPMC EPHE CNRS CORDELIERS PSL SORBONNE-UNIVERSITE SU-SCIENCES UP-SANTE
21 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More